BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21333117)

  • 21. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of drug-induced hyperuricaemia on renal function in Nigerians with pulmonary tuberculosis.
    Adebisi SA; Oluboyo PO; Okesina AB
    Afr J Med Med Sci; 2000; 29(3-4):297-300. PubMed ID: 11714010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple small bowel perforations in a patient on treatment of tuberculosis.
    Scriven JM; Berry D
    J R Coll Surg Edinb; 1996 Oct; 41(5):353. PubMed ID: 8908966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rifampicin-induced acute kidney injury during the initial treatment for pulmonary tuberculosis: a case report and literature review.
    Chiba S; Tsuchiya K; Sakashita H; Ito E; Inase N
    Intern Med; 2013; 52(21):2457-60. PubMed ID: 24190152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
    Knop P; Kindler U; Merholz T
    Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308
    [No Abstract]   [Full Text] [Related]  

  • 26. [Vesicular eruption in a patient under antituberculosis treatment].
    Garrido-Colmenero C; Ruiz-Villaverde R; Martínez-López A; Aneiros-Fernández J
    Med Clin (Barc); 2016 Mar; 146(5):e29. PubMed ID: 26602314
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolonged renal failure after rifampin.
    Bansal VK; Bennett D; Molnar Z
    Am Rev Respir Dis; 1977 Jul; 116(1):137-40. PubMed ID: 879592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
    Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Tarasova EF; Sagalovich VIa
    Probl Tuberk; 1974; (12):26-30. PubMed ID: 4445131
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rifapex, a new antituberculosis agent].
    Sokolova GB; Krasnov VA; Reĭkhrud TA; Tsybanev AA
    Antibiot Khimioter; 2009; 54(1-2):38-41. PubMed ID: 19499716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rifampicin in the treatment of newly detected destructive pulmonary tuberculosis].
    Khomenko AG; Chukanov VI
    Probl Tuberk; 1978 Jun; (6):14-20. PubMed ID: 353801
    [No Abstract]   [Full Text] [Related]  

  • 33. Pulmonary tuberculosis initial treatment.
    N Z Med J; 1978 May; 87(611):321-2. PubMed ID: 276705
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 35. Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis.
    Kohler LJ; Gohara AF; Hamilton RW; Reeves RS
    Clin Nephrol; 1994 Oct; 42(4):263-5. PubMed ID: 7834920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 37. Recurrent disseminated intravascular coagulation caused by intermittent dosing of rifampin.
    Havey TC; Cserti-Gazdewich C; Sholzberg M; Keystone JS; Gold WL
    Am J Trop Med Hyg; 2012 Feb; 86(2):264-7. PubMed ID: 22302861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of tuberculosis. A care program carried out by a working group in the Swedish Pulmonary Medical Society].
    Boman G; Dahlström G; Hanngren A; Stavenow S; Wiman LG
    Lakartidningen; 1976 Sep; 73(40):3321-7. PubMed ID: 966890
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug-induced nephropathy in patients with tuberculosis of the lungs].
    Shutskaia EI; Priakhina VN; Kolpakova TA; Kurilovich GM
    Probl Tuberk; 1991; (4):48-9. PubMed ID: 1852744
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute renal failure and severe thrombocytopenia induced by rifampicin: report of a case.
    Juang YC; Tsao TC; Chiang YC; Lin JL; Tsai YH
    J Formos Med Assoc; 1992 Apr; 91(4):475-6. PubMed ID: 1358323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.